Sexual function after prostate biopsy: overall results and findings within the cancer subgroup
Overall sexual function scores showed no significant change. Men diagnosed with prostate cancer had score declines relative to their own starting scores.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The abstract reports no statistically significant overall change in erectile or ejaculatory function after transperineal biopsy. Men diagnosed with prostate cancer had lower questionnaire scores than at their own baseline. These observations do not establish that biopsy caused the changes or that sexual function was unaffected in every patient.
The abstract reports follow-up only through 3 months and gives no results from an unbiopsied comparison group. It cannot establish whether the subgroup's score changes persisted.
What researchers found
Erectile and ejaculatory function
Overall cohort at 1 and 3 months after biopsy versus its own baseline; questionnaire assessments.
What was measured
Researchers used questionnaires to assess erection and ejaculation before biopsy and during follow-up. The abstract does not quantify score changes or explain how to interpret the direction of each scale.
Understanding the subgroup
Among 132 men diagnosed with prostate cancer, scores declined significantly from their own baseline at both follow-up assessments. This finding within the subgroup does not establish a difference between men with and without cancer.
The original publication
Does Transperineal Prostate Biopsy Affect Sexual Function? Results from a Prospective Cohort Study.
Kucuker K, Simsek A, Kirdar M et al.
J Clin Med · 2026
- PubMed ID
- 41682945
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.